64 Chapter 4 REFERENCE LIST 1. Rae C, Furlong W, Horsman J, Pullenayegum E, Demers C, St-Louis J, et al. Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life. Haemophilia. 2013;19(3):385-91. 2. Knol HM, Bogchelman DH, Kluin-Nelemans HC, van der Zee AG, van der Meer J, Meijer K. Routine evaluation and treatment of unexplained menorrhagia: do we consider haemostatic disorders? Eur J Obstet Gynecol Reprod Biol. 2010;152(2):191-4. 3. James AH. Women and bleeding disorders. Haemophilia. 2010;16 Suppl 5:160-7. 4. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, et al. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010;8(9):2063-5. 5. Biss TT, Blanchette VS, Clark DS, Bowman M, Wakefield CD, Silva M, et al. Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost. 2010;8(5):950-6. 6. Halimeh S, Rott H, Kappert G. PBAC score: an easyto-use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding. Haemophilia. 2016;22(3):e217-20. 7. Herman MC, Mak N, Geomini PM, Winkens B, Mol BW, Bongers MY, et al. Is the Pictorial Blood Loss Assessment Chart (PBAC) score associated with treatment outcome after endometrial ablation for heavy menstrual bleeding? A cohort study. BJOG. 2017;124(2):277-82. 8. Beelen P, van der Velde M, Herman MC, Geomini PM, van den Brink MJ, Duijnhoven RG, et al. Treatment of women with heavy menstrual bleeding: Results of a prospective cohort study alongside a randomised controlled trial. Eur J Obstet Gynecol Reprod Biol. 2021;257:1-5. 9. Penninx JPM, Herman MC, Mol BW, Bongers MY. Five-year follow-up after comparing bipolar endometrial ablation with hydrothermablation for menorrhagia. Obstet Gynecol. 2011;118(6):1287-92. 10. Rubin G, Wortman M, Kouides PA. Endometrial ablation for von Willebrand disease-related menorrhagia--experience with seven cases. Haemophilia. 2004;10(5):477-82. 11. El-Nashar SA, Hopkins MR, Feitoza SS, Pruthi RK, Barnes SA, Gebhart JB, et al. Global endometrial ablation for menorrhagia in women with bleeding disorders. Obstet Gynecol. 2007;109(6):1381-7. 12. Alesci SR, Schrumpf, L.; Krekeler, S.; Miesbach, W. Gynecological surgery and obstetrical procedures in patients with bleeding disorders (von Willebrand Disease and carriers for haemophilia) Hamostaseologie. 2012;2012(1):A43. 13. Huq FY, Al-Haderi M, Kadir RA. The outcome of endometrial ablation in women with inherited bleeding disorders. Haemophilia. 2012;18(3):413-20. 14. Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51(11):1055-68. 15. Higham JM, O’Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990;97(8):734-9. 16. Huser M, Papikova Z, Dziakova M, Hudecek R, Ventruba P. Radiofrequency endometrial ablation - new possibility of heavy menstrual bleeding conservative treatment. Ceska Gynekol.83(6):418-23. 17. Munro MG, Critchley HOD, Fraser IS, Committee FMD. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393-408. 18. Latthe P, Mignini L, Gray R, Hills R, Khan K. Factors predisposing women to chronic pelvic pain: systematic review. BMJ. 2006;332(7544):749-55. 19. Deligeoroglou E, Athanasopoulos N, Tsimaris P, Dimopoulos KD, Vrachnis N, Creatsas G. Evaluation and management of adolescent amenorrhea. Ann N Y Acad Sci. 2010;1205:23-32. 20. Unsal A, Ayranci U, Tozun M, Arslan G, Calik E. Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students. Ups J Med Sci. 2010;115(2):138-45. 21. Doherty D, Grabell J, Christopherson PA, Montgomery RR, Coller BS, Lavin M, et al. Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance. J Thromb Haemost. 2022. 22. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692-4.
RkJQdWJsaXNoZXIy MTk4NDMw